eCARTv5 Clinical Deterioration Suite (eCART) vs ClosedLoop.ai

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

eCARTv5 Clinical Deterioration Suite (eCART)

by AgileMD

ClosedLoop.ai

by ClosedLoop.ai

AI Verdict

Tool A, AgileMD's eCARTv5, is a specialized, FDA-cleared AI-powered Software as a Medical Device focused on continuously predicting and managing clinical deterioration in hospitalized adult patients. Tool B, ClosedLoop.ai, is a broader healthcare-specific AI data science platform that enables organizations to build, deploy, and manage various predictive models for a wider range of patient outcomes and cost reduction. While both leverage AI for predictive analytics in healthcare, eCARTv5 offers a pre-built, targeted solution for a specific clinical problem, whereas ClosedLoop.ai provides a platform for developing custom AI solutions across diverse healthcare challenges.

Choose eCARTv5 Clinical Deterioration Suite (eCART) if…

Choose eCARTv5 Clinical Deterioration Suite if your primary need is an FDA-cleared, real-time AI-powered early warning system to continuously monitor hospitalized adult patients for clinical deterioration (death or ICU transfer). This tool excels at integrating directly with EHRs to provide continuous risk assessment and guide care with embedded clinical pathways, aiming to reduce false alarms and clinician workload.

View eCARTv5 Clinical Deterioration Suite (eCART) →

Choose ClosedLoop.ai if…

Choose ClosedLoop.ai if your organization requires a comprehensive healthcare-specific AI data science platform to build, deploy, and manage custom predictive models for a wide range of patient outcomes and cost reduction initiatives. This platform is ideal for organizations looking to leverage diverse healthcare data (EHR, claims, SDoH) to predict things like readmissions, avoidable ED visits, and cost bloomers, and to optimize care management and value-based care strategies.

View ClosedLoop.ai →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	eCARTv5 Clinical Deterioration Suite (eCART)	ClosedLoop.ai
Pricing	Contact vendor for tailored quote.	Not publicly available; requires contacting sales for a demo and quote.
Deployment	Cloud-based SaaS, integrated directly into Electronic Health Record (EHR) systems.	Cloud-based environment
FDA Status	1 AI-estimated	Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

eCARTv5 Clinical Deterioration Suite (eCART)

eCARTv5 is designed as an integrated clinical decision support tool within the EHR, suggesting a focus on seamless workflow and ease of use for clinicians. ClosedLoop.ai, while powerful, is a platform for building and deploying models, which implies a higher technical barrier for end-users and a focus on data scientists and developers rather than direct clinical usability.

Clinical Value

eCARTv5 Clinical Deterioration Suite (eCART)

eCARTv5 is an FDA-cleared SaMD specifically designed to predict clinical deterioration and guide care with embedded pathways, directly impacting patient outcomes in critical care settings. ClosedLoop.ai offers a platform to build predictive models for various outcomes, but eCARTv5's direct application and regulatory clearance for a specific clinical problem give it a more immediate and proven clinical value.

Pricing & Value

Tie

Both tools require contacting the vendor for a tailored quote, making a direct comparison of pricing difficult. ClosedLoop.ai does offer a free solution (ACO-Predict) for Medicare ACOs, which provides some transparency and potential value for a specific segment. However, without more detailed pricing for the full platforms, it's a tie.

Enterprise Readiness

Tie

Both tools are cloud-based SaaS solutions with HIPAA compliance and BAA agreements, indicating readiness for enterprise deployment. eCARTv5 integrates with EHRs, a critical aspect for healthcare enterprises, while ClosedLoop.ai serves organizations of all sizes and has SOC2 and GDPR compliance, demonstrating broad enterprise capabilities. Without further details on scalability or specific enterprise client testimonials for both, it's a tie.

Innovation

Tie

eCARTv5's continuous, real-time risk assessment using up to 97 variables and embedded clinical pathways represents significant innovation in proactive clinical deterioration management. ClosedLoop.ai's platform approach to enabling organizations to build, deploy, and manage custom predictive models for diverse healthcare challenges is also highly innovative, empowering data science teams. Both offer distinct but equally innovative approaches within healthcare AI.

Support & Docs

Tie

Neither the provided structured facts nor general web searches offer specific details about the depth or breadth of support and documentation for either eCARTv5 or ClosedLoop.ai. Without this information, it is not possible to definitively pick a winner in this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	eCARTv5 Clinical Deterioration Suite (eCART)	ClosedLoop.ai
Name	eCARTv5 Clinical Deterioration Suite (u0093eCARTu0094)	ClosedLoop.ai
Company	AgileMD	ClosedLoop.ai
Description	FDA-cleared, AI-powered Software as a Medical Device (SaMD) that integrates with EHRs to continuously assess and predict the risk of clinical deterioration (death or ICU transfer) in hospitalized adult patients, guiding care with embedded clinical pathways.	A healthcare-specific AI data science platform that enables organizations to build, deploy, and manage predictive models to improve patient outcomes and reduce costs.
Key Features	AI-powered clinical deterioration prediction; Continuous patient risk assessment (death or ICU transfer); EHR integration with real-time data (up to 97 variables); Embedded clinical pathways for care guidance; Early warning system (alerts hours before critical illness); Risk stratification (eCART score and risk designation); Minimizes false alarms and clinician workload; Reporting and benchmarking capabilities	Healthcare-specific data ingestion & normalization; Predictive model development & validation; Model deployment & monitoring; Risk stratification capabilities; Care management optimization; Health equity analytics; Value-based care support; Cost and utilization prediction
Specialties	Critical Care, Emergency Medicine, Hospital Medicine	Family Medicine, Hospital Medicine, Internal Medicine

Videos

Demos, reviews, and walkthroughs featuring eCARTv5 Clinical Deterioration Suite (eCART) and ClosedLoop.ai.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools integrate into existing EHR workflows and what is the depth of that integration?

eCARTv5 is designed for direct integration into EHR systems, continuously analyzing up to 97 real-time variables from patient data like vital signs, lab results, and nursing assessments to generate risk scores and guide care with embedded clinical pathways. ClosedLoop.ai, as a data science platform, can ingest and normalize various healthcare data streams, including EHR, claims, labs, and social determinants of health, to build and deploy predictive models, with some solutions like ACO-Predict requiring no IT integration as data flows directly from CMS.

What is the proven accuracy and sensitivity of each tool in predicting patient outcomes?

eCARTv5 has demonstrated high accuracy in predicting clinical deterioration (death or ICU transfer), with an AUROC of 0.834 in retrospective validation and 0.828 in prospective validation, outperforming other early warning scores. ClosedLoop.ai's algorithms have shown an increased accuracy of 41% compared to traditional risk scores in identifying high-risk patients for value-based care programs.

What is the typical learning curve for physicians and other clinical staff to effectively use these tools in their daily practice?

eCARTv5 is intended to aid clinical teams by providing a risk score and trend analysis to identify patients likely to deteriorate, directing them to standardized guidance within the eCART interface. ClosedLoop.ai focuses on delivering personalized forecasts directly into clinical workflows, with explainable AI that surfaces key variables and links to specific interventions, which aims to make the insights actionable for clinicians.

What kind of customer support and resources are available for ongoing optimization and troubleshooting?

While specific details on support quality are not provided for eCARTv5, its development involved extensive research and validation, suggesting a robust foundation. ClosedLoop.ai has received high customer satisfaction ratings, with all customers in a KLAS report stating they would buy from the company again and that the company keeps its promises.

Beyond HIPAA, what additional security measures and audit-trail features are in place to protect patient data and ensure accountability?

ClosedLoop.ai is SOC2 and GDPR compliant, indicating adherence to broader security and data privacy frameworks beyond HIPAA. While specific audit-trail features are not detailed for either, ClosedLoop.ai's focus on explainable AI and its use in critical decision-making suggests a need for transparent and auditable processes.

How do these tools support multi-site rollouts, and what considerations should be made for consistent implementation across different hospital environments?

eCARTv5 has been validated across a geographically diverse set of health systems and 21 hospitals, suggesting its adaptability for multi-site deployments. ClosedLoop.ai serves organizations of all sizes, from small regional provider networks to large national health plans, indicating its scalability for multi-site rollouts and diverse healthcare environments.

In what specific clinical contexts would each tool provide the most significant value for a physician?

eCARTv5 offers significant value in critical care, emergency medicine, and hospital medicine by providing early warning of clinical deterioration (death or ICU transfer) in hospitalized adult patients, with embedded clinical pathways to guide care. ClosedLoop.ai is valuable across various specialties, including family medicine, hospital medicine, and internal medicine, by enabling organizations to build predictive models for use cases like readmission reduction, care management optimization, and population health risk stratification.